BNC210

CAS No. 13589-06-5

BNC210( H-Ile-Trp-OH | IW-2143 )

Catalog No. M21627 CAS No. 13589-06-5

BNC210 is a α7 nAChR negative allosteric modulator. BNC210 has potent activity in animal models of anxiety and depression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 39 In Stock
50MG 63 In Stock
100MG 91 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BNC210
  • Note
    Research use only, not for human use.
  • Brief Description
    BNC210 is a α7 nAChR negative allosteric modulator. BNC210 has potent activity in animal models of anxiety and depression.
  • Description
    BNC210 is a α7 nAChR negative allosteric modulator. BNC210 has potent activity in animal models of anxiety and depression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    H-Ile-Trp-OH | IW-2143
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    α7 nAChR
  • Research Area
    Neurological Disease
  • Indication
    Post-Traumatic Stress Disorder

Chemical Information

  • CAS Number
    13589-06-5
  • Formula Weight
    317.38
  • Molecular Formula
    C17H23N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (393.85 mM; Need ultrasonic)
  • SMILES
    CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Toby Wise Fiona Patrick Nicholas Meyeret al.Cholinergic Modulation of Disorder-Relevant Neural Circuits in Generalized Anxiety Disorder.Biol Psychiatry. 2020 May 15;87(10):908-915.
molnova catalog
related products
  • Pempidine

    Pempidine is a ganglion-blocking drug, introduced as an oral treatment for hypertension.

  • (-)-vibo-Quercitol

    (-)-vibo-Quercitol is a carbaglycosylamine glycosidase inhibitor.

  • α-Conotoxin AuIB

    Selective antagonist of α3β4 nicotinic acetylcholine receptors. Displays > 100-fold selectivity over other receptor subunit combinations including α2β2, α2β4, α3β2, α4β2, α4β4 and α1β1γδ.